Bessemer Group Inc Tandem Diabetes Care Inc Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Bessemer Group Inc holds 22,227 shares of TNDM stock, worth $684,813. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,227

Previous 22,060 0.76%

Holding current value

$684,813

Previous $888,000 6.08%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$35.21 - $47.3 $5,880 - $7,899	167 Added 0.76%	22,227 $942,000
Q2 2024 Aug 13, 2024	BUY	$30.43 - $53.43 $53,556 - $94,036	1,760 Added 8.67%	22,060 $888,000
Q1 2024 May 13, 2024	BUY	$22.09 - $35.41 $3,313 - $5,311	150 Added 0.74%	20,300 $719,000
Q4 2023 Feb 09, 2024	BUY	$14.28 - $31.03 $72,542 - $157,632	5,080 Added 33.71%	20,150 $596,000
Q3 2023 Nov 13, 2023	BUY	$19.33 - $36.22 $124,214 - $232,749	6,426 Added 74.34%	15,070 $313,000
Q2 2023 Aug 10, 2023	BUY	$24.18 - $42.46 $209,011 - $367,024	8,644 New	8,644 $212,000
Q4 2022 Feb 13, 2023	SELL	$35.49 - $56.15 $1,880 - $2,975	-53 Closed	0 $0
Q3 2022 Nov 09, 2022	BUY	$43.76 - $68.97 $787 - $1,241	18 Added 51.43%	53 $3,000
Q1 2022 May 12, 2022	BUY	$101.89 - $150.09 $509 - $750	5 Added 16.67%	35 $4,000
Q4 2021 Jan 27, 2022	BUY	$118.18 - $153.21 $3,545 - $4,596	30 New	30 $5,000
Q2 2020 Aug 05, 2020	SELL	$60.05 - $98.92 $429,777 - $707,970	-7,157 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$47.37 - $90.04 $339,027 - $644,416	7,157 New	7,157 $461,000
Q2 2018 Jul 25, 2018	SELL	$4.9 - $23.64 $769 - $3,711	-157 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$2.35 - $4.96 $368 - $778	157 New	157 $1,000

Others Institutions Holding TNDM

# of Institutions

360

Shares Held

72.5M

Call Options Held

3.36M

Put Options Held

229K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.98B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Tandem Diabetes Care Inc Transaction History